Abstract:Anaplastic thyroid cancer (ATC) represents the most aggressive subtype of thyroid cancer and has a poor prognosis. In addition to surgery, chemotherapy is an important treatment for ATC; however, the therapeutic effects of current chemotherapies for ATC are not particularly promising. There is a high proportion of side population (SP) cells in ATC, which may be a reason for its drug resistance. In the present study, the antitumor activities of combined octreotide (OCT) and cisplatin (DDP) on the proliferation and apoptosis of ATC SP cells were evaluated. First, SP cells from 8305C and BHT101 cell lines were detected and sorted. Following in vitro culture for 1 week, cluster of differentiation (CD)44, CD133, ATP-binding cassette (ABC) subfamily B member 1 (ABCB1), ABC subfamily G member 2 (ABCG2) and somatostatin receptor expression was detected to characterize the SP cells. An MTT assay was performed to investigate the combined effects on 8305C-SP cell proliferation in vitro, and a mouse model was used to investigate the combined effects on 8305C-SP cell proliferation in vivo. Annexin V/propidium iodide staining was used to investigate the combined effects on 8305C-SP cell apoptosis. Chemotherapeutic drug resistance-associated protein expression and apoptosis-associated protein expression were also detected following combined treatment. As a result, SP cells were identified in 8305C and BHT101 cells, and the proportion of 8305C-SP cells was increased compared with that of BTH101-SP cells. SP cells have enhanced proliferation, tumorigenicity and drug resistance compared with main population cells. The combined treatment of OCT with DDP suppressed the proliferation of 8305C-SP cells in vitro and in vivo, and induced 8305C-SP cell apoptosis. Combined treatment decreased the ABCB1 and ABCG2 expression by SP cells and activated mitochondrial apoptotic signaling, resulting in cell apoptosis. In conclusion, these data support the hypothesis that combined treatment with OCT and DDP induces ATC cell apoptosis and suppresses cell proliferation. These data provide a theoretical basis for further combined chemotherapy clinical applications.

Resveratrol Suppresses The Growth And Enhances Retinoic Acid Sensitivity Of Anaplastic Thyroid Cancer Cells

Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells

Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations

Resveratrol Reverses Retinoic Acid Resistance of Anaplastic Thyroid Cancer Cells via Demethylating CRABP2 Gene.

ATRA Increases Iodine Uptake and Inhibits the Proliferation and Invasiveness of Human Anaplastic Thyroid Carcinoma SW1736 Cells: Involvement of Β-Catenin Phosphorylation Inhibition.

Clinical Study of All-trans-retinoic Acid in Redifferentiation Therapy for Thyroid Cancer

[Beneficial Effects of Retinoic Acid on in Vitro Invasiveness of Human Thyroid Carcinoma Cell Lines].

REGγ Ablation Impedes Dedifferentiation of Anaplastic Thyroid Carcinoma and Accentuates Radio-Therapeutic Response by Regulating the Smad7-TGF-β Pathway.

Efficacy and Safety of 13-Cis Retinoid Acid and All Trans Retinoid Acid in the Redifferentiation Therapy of Poorly Differentiated Thyroid Cancer

A Clinical Study of All-Trans-retinoid-induced Differentiation Therapy of Advanced Thyroid Cancer

All-Trans Retinoic Acid Suppresses Malignant Characteristics Of Cd133-Positive Thyroid Cancer Stem Cells And Induces Apoptosis

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.

Thyroid hormone receptor α1: a novel regulator of thyroid cancer cell differentiation

Suberoyl Bis-Hydroxamic Acid Activates Notch1 Signaling and Induces Apoptosis in Anaplastic Thyroid Carcinoma Through P53.

1,25‑Dihydroxyvitamin D3 Enhances the Susceptibility of Anaplastic Thyroid Cancer Cells to Adriamycin‑induced Apoptosis by Increasing the Generation of Reactive Oxygen Species

All-trans Retinoic Acid (ATRA) Inhibits Insufficient Radiofrequency Ablation (Irfa)-Induced Enrichment of Tumor-Initiating Cells in Hepatocellular Carcinoma.

Advances in targeted therapy for anaplastic thyroid carcinoma

UHRF1 Suppression Promotes Cell Differentiation and Reduces Inflammatory Reaction in Anaplastic Thyroid Cancer

Combined Effects of Octreotide and Cisplatin on the Proliferation of Side Population Cells from Anaplastic Thyroid Cancer Cell Lines

The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment